Kelly J Gaffney

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Venous Thromboembolism

Multiple Myeloma

Chronic Lymphocytic Leukemia

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Annals of hematology

Clinical hematology international

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Kelly J Gaffney, Jonathan K Bakos, Arash Velayati, James A Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, Deidra Smith, Kimberly Green, Brian T Hess, Hamza Hashmi
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Mary McGann, Arash Velayati, Kiera Roubal, Katelynn Granger, James A Davis, Kelly J Gaffney, Erin Weeda, Hamza Hashmi
Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies. Leukemia & lymphoma (2023)
Kelly J Gaffney, Mary McGann, James A Davis, Kathy H Edwards, Hamza Hashmi
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy. Annals of hematology 102 (3) (2023)
Katelynn Granger, Kelly J Gaffney, James A Davis
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Kelly J Gaffney, Mary McGann, James A Davis, Kathy H Edwards, Hamza Hashmi
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy. Annals of hematology 102 (3) (2023)
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Lisa Rybicki, Navneet S Majhail, Sherif Beniameen Mossad
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period. Clinical hematology international (2023)
Kelly J Gaffney, Mary McGann, James A Davis, Kathy H Edwards, Hamza Hashmi
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy. Annals of hematology 102 (3) (2023)
Kelly J Gaffney, James A Davis, Mary McGann, Kathy Edwards, Zaheer Ahmed, Colleen Butcher, Brian Greenwell, Brian T Hess, Hamza Hashmi
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Kelly J Gaffney, Mary McGann, James A Davis, Kathy H Edwards, Hamza Hashmi
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy. Annals of hematology (2023)
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Faiz Anwer, Robert M Dean, Aaron T Gerds, Betty K Hamilton, Deepa Jagadeesh, Matt E Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S Majhail, Brian T Hill
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Abigail Shockley, James A Davis, Kelly J Gaffney, Deidra Smith, Erin Weeda, Hamza Hashmi
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (7) (2022)
James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney, Mary McGann, Alyssa M Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T Hess
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies. Blood (2022)